FDA panel rejects COVID vaccine booster for broad use – What does that mean for you?

Brian Althimer

3 years ago

FILE - In this March 2, 2021, file photo, Hollie Maloney, a pharmacy technician, loads a syringe with Pfizer's COVID-19 vaccine at the Portland Expo in Portland, Maine. An influential federal advisory panel overwhelmingly rejected a plan Friday, Sept. 17, to offer Pfizer booster shots against COVID-19 to most Americans, dealing a heavy blow to the Biden administration’s effort to shore up people’s protection amid the highly contagious delta variant. (AP Photo/Robert F. Bukaty, File)

Dr. Robert Murphy, Professor of Infectious Diseases at Northwestern University Feinberg School of Medicine, joins Jon Hansen (filling-in for Steve Bertrand) on Chicago’s Afternoon News to explain why advisers to the U.S. Food and Drug Administration decided to only allow emergency use of COVID-19 vaccine booster shots for people 65 and up and those at high risk of severe illness.

https://serve.castfire.com/audio/3876867/3876867_2021-09-17-222507.64kmono.mp3

“Better knowledge means better health for you and your family. Turn to Northwestern Medicine at nm.org/healthbeatnews for health tips, research and more.”

Follow Your Favorite Chicago’s Afternoon News Personalities on Twitter:
Follow @SteveBertrand Follow @kpowell720 Follow @maryvandevelde Follow @LaurenLapka